Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Acquisitions & Divestments: 2015-2019

Historic Change in Acquisitions & Divestments for Fortress Biotech (FBIO) over the last 4 years, with Dec 2019 value amounting to $22.6 million.

  • Fortress Biotech's Change in Acquisitions & Divestments fell 50.00% to $5.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $32.6 million, marking a year-over-year decrease of 54.08%. This contributed to the annual value of $22.6 million for FY2019, which is 68.16% down from last year.
  • Latest data reveals that Fortress Biotech reported Change in Acquisitions & Divestments of $22.6 million as of FY2019, which was down 68.16% from $71.0 million recorded in FY2018.
  • In the past 5 years, Fortress Biotech's Change in Acquisitions & Divestments ranged from a high of $99.9 million in FY2015 and a low of $20.1 million during FY2017.
  • Over the past 3 years, Fortress Biotech's median Change in Acquisitions & Divestments value was $22.6 million (recorded in 2019), while the average stood at $37.9 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first spiked by 253.44% in 2018, then tumbled by 68.16% in 2019.
  • Yearly analysis of 4 years shows Fortress Biotech's Change in Acquisitions & Divestments stood at $99.9 million in 2015, then reached $20.1 million in 2017, then skyrocketed by 253.44% to $71.0 million in 2018, then tumbled by 68.16% to $22.6 million in 2019.